Published: June 01, 2002Received: -Available on J-STAGE: June 28, 2010Accepted: -
Advance online publication: -
Revised: -
Correction information
Date of correction: June 28, 2010Reason for correction: -Correction: KEYWORDDetails: Right : PMEA coating, X Coating
Date of correction: June 28, 2010Reason for correction: -Correction: CITATIONDetails: Wrong : E E E E E E E E E
Right : 1)Journois D, et al. : High volume, zero-balanced hemofiltration to reduce delayed inflammatory response to Cardiopulmonary bypass in children. Anesthesiology, 85; 965-76, 1996. 2)Segaye M, et al. : Interleukin-10release related to Cardiopulmonary bypass in inflants undergoing cardiac operations. J Thorac Cardiovasc Surg, 111; 545-53, 1996. 3)Gorman RC. et al. : Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. Journal of Thoracic&Cardiovascular Surgery, 111(1); 1-11, 1996 4)Horimoto H. et al. : Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery. Artificial Organs, 20(8); 936-940, 1996. 5)Hazlewood CF, Nicols BL, Chamberlain NF; Nature, 222; 747, 1969. 6)Uedaira H: Hyoumen, 13, 302, 1975. 7)Lyne Schiel, Steve Burns, Atsuhiko Nogawa, et al. : X COATINGTM: A NEW BIOPASSIVE POLYMER COATING. CANADIAN PERFUSION CANADIENNE, 11(2); 8-17, 2001. 8)Masaru Tanaka et al. : Blood compatible aspects of PMEA-relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterial, 21; 1471-1481, 2000. 9)LB Mongero, JR Beck, HE Manspeizer, et al. : Cardio surgical patients exposed to heparin-bonded circuits develop less postoperative cerebral dysfunction than patients exposed to non-heparin-bonded circuits. Perfusion, 16; 107-111, 2001.